Prednisone in Hypothyroidism
Prednisone is safe to use in patients with hypothyroidism, but requires critical attention to two key interactions: glucocorticoids can suppress TSH levels and alter thyroid hormone metabolism, and patients with untreated or undertreated adrenal insufficiency must receive glucocorticoid coverage before initiating or increasing levothyroxine therapy.
Safety and Key Precautions
Prednisone can be safely administered to hypothyroid patients, but the interaction works in both directions and requires specific management:
Critical Warning: Adrenal Insufficiency Risk
In patients with suspected or confirmed adrenal insufficiency (either primary or central), glucocorticoid therapy must be initiated BEFORE starting or increasing levothyroxine. 1 Thyroid hormone replacement can precipitate adrenal crisis in these patients by increasing cortisol metabolism. While this scenario is rare, it can be life-threatening. If adrenal insufficiency is present, elevated TSH levels may normalize with glucocorticoid therapy alone, initially mimicking subclinical hypothyroidism 1.
Effect on Thyroid Function Monitoring
Glucocorticoids directly affect thyroid hormone levels and TSH secretion through multiple mechanisms 1:
TSH suppression: Prednisone suppresses TSH release at the hypothalamic-pituitary level without necessarily changing circulating thyroid hormone concentrations 2, 3. In hypothyroid patients on levothyroxine replacement, prednisone 20 mg daily for 9 days decreased TSH levels by approximately 46% without significant changes in T4 or T3 2.
Peripheral metabolism: Glucocorticoids inhibit peripheral conversion of T4 to T3 1, which can reduce active thyroid hormone availability.
Pharmacokinetic alterations: In untreated hypothyroidism, prednisone and prednisolone clearance is markedly impaired, with AUC increases of 15-fold for prednisone and 5-fold for prednisolone compared to euthyroid controls 4. This normalizes with thyroid hormone replacement therapy.
Dosing Recommendations
Standard prednisone dosing applies to hypothyroid patients, with the following considerations:
- Initial dosing: 5-60 mg daily depending on the condition being treated 5
- Timing: Administer in the morning (before 9 AM) to minimize HPA axis suppression 5
- Tapering: Never stop abruptly; gradual dose reduction is mandatory 5
For patients on chronic medium-to-high dose glucocorticoids (>7.5 mg prednisone equivalent daily for >3 weeks), anticipate HPA axis suppression and provide stress-dose coverage during acute illness or surgery 6.
Monitoring Strategy
When prednisone is used in hypothyroid patients on levothyroxine replacement:
Delay thyroid function testing during daily prednisone therapy: Total T4 levels decrease significantly after 7 days of daily prednisone (1 mg/kg), though free T4 remains more stable 7. If monitoring is necessary during treatment, measure free T4 rather than total T4.
Recheck thyroid function 4-8 weeks after starting or stopping prednisone: When glucocorticoids are introduced or discontinued, thyroid hormone levels should be rechecked within 4-8 weeks, then every 4-8 weeks until stable 1.
Alternate-day dosing causes less interference: Every-other-day prednisone administration does not significantly interfere with thyroid hormone monitoring 7.
Watch for falsely reassuring TSH: Prednisone-induced TSH suppression may mask inadequate thyroid hormone replacement. If clinical hypothyroid symptoms persist despite "normal" TSH on prednisone, consider measuring free T4 directly.
Additional Precautions in Hypothyroid Patients
Enhanced glucocorticoid effect: Hypothyroid patients have enhanced sensitivity to corticosteroid effects due to decreased metabolism 5. This may necessitate dose adjustments.
Bone protection: Initiate calcium and vitamin D supplementation for any patient anticipated to receive ≥5 mg prednisone equivalent for ≥3 months 6, 5. Consider bisphosphonate therapy if bone mineral density is below normal.
Cardiovascular monitoring: Both hypothyroidism and glucocorticoids increase cardiovascular risk. Monitor blood pressure, as hypertension occurs in 3-28 per 100 patient-years on chronic medium-dose glucocorticoids 6.
Common Pitfalls to Avoid
Do not increase levothyroxine dose based solely on TSH during prednisone therapy - the TSH suppression is a direct drug effect, not true hypothyroidism.
Do not assume euthyroidism based on normal TSH in a symptomatic patient on prednisone - check free T4 to confirm adequate replacement.
Do not start or increase levothyroxine in patients with possible adrenal insufficiency without glucocorticoid coverage - this can precipitate adrenal crisis 1.
Do not forget to reassess thyroid function after prednisone discontinuation - TSH may transiently increase above baseline (rebound effect) before returning to true baseline 2, 3.